Please email us at [email protected] with our item No, NDC#, UPC# or the product link if you have any quetions. We are located in Oceanside, California. Search over 110,000 items by Name, Item No., NDC, UPC (without dashes) or by Mfg.Name. Please note, Prescription items can only be ordered by a Drug Manufacturer, Wholesaler, Hospital, Governmental Medical Facility, VA, Pharmacy, Physician, Physician Assistant, Nurse Practitioner, Dentist, Podiatrist, Optometrist, Veterinarian, Naturopath, Licensed Lab, Physical Therapist & Pharmacist in their scope of practice. No order will ship, unless you you have provided us the Medical License (and DEA Lic. in case of controlled drug) and we had verified that. Rx items can only be shipped to AZ, AR, CA, CT, DE, FL, GA, GU, HI, IL, KS, KY, LA, ME, MA, MI, NJ, NY, PA, PR, TX, TN, VA, WA, WI and WV. If you are an International Physician or Pharmacist, please contact us before ordering.


Menu

Rx Item-Suprane Liq 6X240Ml By Baxter Pharma

NDC 10019-0641-34 UPC/GTIN No.3-10019-64134-8 Mfg.Part No.64134BRAND: SUPRANE NDC: 10019-0641-34,10019064134 UPC: 3-10019-64134-8,310019641348 Baxter Pharma USAOnly Lic.-Physician,Pharmacy,Dentist,Drug Mfg,Dist.,Gov,Hospital,Lic.Lab,Naturalist,Naturopath,NP,Optometrist,Pharmacist,PA,Physical Therapist,Podiatrist,Research Co.,Uni.,VA,Vet & Wholesalers in scopWant to do Research on this Med or need a large quantity? Email Details with quantity required to:sales@AmericanPharmaWholesale.comVisit AmericanPharmaWholesale.com for over 100,000 items of Health & Beauty at Retail@Wholesale prices.

Rx Item-Suprane Liq 6X240Ml By Baxter Pharma

$1153.58$1048.11

Item No.: RX225607 NDC No.10019064134 UPC No.:310019641348 NDC No.10019-0641-34 UPC/GTIN No.3-10019-64134-8 MPN 64134 Only Lic.-Physician,Pharmacy,Dentist,Drug Mfg,Dist.,Gov,Hospital,Lic.Lab,Naturalist,Naturopath,NP,Optometrist,Pharmacist,PA,Physical Therapist,Podiatrist,ResearchCo.,Uni.,VA,Vet & Wholesalers in scope of practice can order this RX Item. Rx Item No.Rx225607 Suprane Liq 6X240ml by Baxter Acc Item No.3225607 NDC No.10019064134 UPC No.310019641348 Other Name Suprane Therapeutic Cod

Have a question?

SUPRANE- desflurane liquid
Baxter Healthcare Corporation
1 INDICATIONS AND USAGE
1.1 Induction of Anesthesia

SUPRANE (desflurane, USP) is indicated as an inhalation agent for induction of anesthesia for inpatient and outpatient surgery in adults.

SUPRANE is contraindicated as an inhalation agent for the induction of anesthesia in pediatric patients because of a high incidence of moderate to severe upper airway adverse events.
1.2 Maintenance of Anesthesia

SUPRANE is indicated as an inhalation agent for maintenance of anesthesia for inpatient and outpatient surgery in adults and in pediatric patients.

After induction of anesthesia with agents other than SUPRANE, and tracheal intubation, SUPRANE is indicated for maintenance of anesthesia in infants and children. SUPRANE is not approved for maintenance of anesthesia in non-intubated children due to an increased incidence of respiratory adverse reactions, including coughing, laryngospasm, and secretions [see Warnings and Precautions (5.3) and Clinical Studies (14.5)].
2 DOSAGE AND ADMINISTRATION

Only persons trained in the administration of general anesthesia should administer SUPRANE. Only a vaporizer specifically designed and designated for use with desflurane should be utilized for its administration. Facilities for maintenance of a patent airway, artificial ventilation, oxygen enrichment, and circulatory resuscitation must be immediately available.
SUPRANE is administered by inhalation. The administration of general anesthesia must be individualized based on the patient's response. Hypotension and respiratory depression increase as anesthesia with SUPRANE is deepened. The minimum alveolar concentration (MAC) of SUPRANE decreases with increasing patient age. The MAC for SUPRANE is also reduced by concomitant N2 O administration (see Table 1). The dose should be adjusted accordingly. The following table provides mean relative potency based upon age and effect of N2 O in predominately ASA physical status I or II patients.

Benzodiazepines and opioids decrease the MAC of SUPRANE [see Drug Interactions (7.1, Table 3)]. SUPRANE also decreases the doses of neuromuscular blocking agents required [see Drug Interactions (7.2, Table 4)]. The dose should be adjusted accordingly.
DOSAGE FORMS AND STRENGTHS

SUPRANE (desflurane, USP) is a colorless, non-flammable, volatile liquid (below 22.8�C) for inhalation, 100% desflurane.
4 CONTRAINDICATIONS

The use of SUPRANE is contraindicated in the following conditions:


Known or suspected genetic susceptibility to malignant hyperthermia.

Patients in whom general anesthesia is contraindicated.

Induction of anesthesia in pediatric patients.

Patients with known sensitivity to SUPRANE or to other halogenated agents [see Warnings and Precautions (5.5)].

Patients with a history of moderate to severe hepatic dysfunction following anesthesia with SUPRANE or other halogenated agents and not otherwise explained [see Warnings and Precautions (5.5)].
PATIENT COUNSELING INFORMATION

Anesthesia providers need to obtain the following information from patients prior to administration of anesthesia:


Medications they are taking, including herbal supplements

Drug allergies, including allergic reactions to anesthetic agents (including hepatic sensitivity)

Any history of severe reactions to prior administration of anesthetic

If the patient or a member of the patient's family has a history of malignant hyperthermia or if the patient has a history of Duchenne muscular dystrophy or other latent neuromuscular disease

Anesthesia providers should inform patients of the risks associated with SUPRANE:


Post-operative nausea and vomiting and respiratory adverse effects including coughing.

There is no information of the effects of SUPRANE following anesthesia on the ability to operate an automobile or other heavy machinery. However, patients should be advised that the ability to perform such tasks may be impaired after receiving anesthetic agents.

NDC 10019-0641-34 UPC/GTIN No.3-10019-64134-8 Mfg.Part No.64134
RX ITEM-Suprane Liq 6X240Ml By Baxter Ph
NDC 10019-0641-34 UPC/GTIN No.3-10019-64134-8 Mfg.Part No.64134

BRAND: SUPRANE NDC: 10019-0641-34,10019064134 UPC: 3-10019-64134-8,310019641348 Baxter Pharma USA
Suprane Liq 6X240Ml By Baxter Pharma
BRAND: SUPRANE NDC: 10019-0641-34,10019064134 UPC: 3-10019-64134-8,310019641348 Baxter Pharma USA

Only Lic.-Physician,Pharmacy,Dentist,Drug Mfg,Dist.,Gov,Hospital,Lic.Lab,Naturalist,Naturopath,NP,Optometrist,Pharmacist,PA,Physical Therapist,Podiatrist,Research Co.,Uni.,VA,Vet & Wholesalers in scop
DESFLURANE INHALATION LIQ
Only Lic.-Physician,Pharmacy,Dentist,Drug Mfg,Dist.,Gov,Hospital,Lic.Lab,Naturalist,Naturopath,NP,Optometrist,Pharmacist,PA,Physical Therapist,Podiatrist,Research Co.,Uni.,VA,Vet & Wholesalers in scop

Want to do Research on this Med or need a large quantity? Email Details with quantity required to:sales@AmericanPharmaWholesale.com
Buy More Save More!
Want to do Research on this Med or need a large quantity? Email Details with quantity required to:[email protected]

Visit AmericanPharmaWholesale.com for over 100,000 items of Health & Beauty at Retail@Wholesale prices.
AmericanPharmaWholesale.com
Visit AmericanPharmaWholesale.com for over 100,000 items of Health & Beauty at Retail@Wholesale prices.